SP-MHCI-0009

Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

US$126.00

In stock

Description

About Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK) - Specifications

Amount: 50 µg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in glass vial
Application(s): T-cell immunity
Condition(s)/Topic(s): Control, Infectious mononucleosis, Opportunistic infections, Cytomegalovirus disease
Standard Delivery Time: 2-5 days

Visit our webpage for more information on Peptide Tools to Study CMV.

Are you interested in your other antigen peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!

References

References for Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

References:
Read References with Antigen Peptides

Documentation

Documentation for Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

Properties

Properties of Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

Properties Values
Allele: HLA-A*03:01, HLA-A*0301
Amount: 50 µg
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Control, Cytomegalovirus disease, Infectious mononucleosis, Opportunistic infections
Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial
Organism: Human Cytomegalovirus (HCMV)
Protein Name: 55 kDa immediate-early protein 1 (IE-1)
Purity: >90% (HPLC-MS), Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: Yes

Further Information to Antigen Peptide CMV IE-1 - HLA-A*0301 (KLGGALQAK)

Information Values
Sequence: H-KLGGALQAK-OH
Specifications: 9mer peptide as TFA salt
Loading...
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote